Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.

Mesenchymal stem cells have been demonstrated to ameliorate experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, prompting clinical trials in multiple sclerosis which are currently ongoing. An important question is whether this therapeutic effect generalises to other autoi...

Full description

Saved in:
Bibliographic Details
Main Authors: Marija Sajic, David P J Hunt, Woojin Lee, D Alastair S Compston, Judith V Schweimer, Norman A Gregson, Siddharthan Chandran, Kenneth J Smith
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0030708&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849727543434805248
author Marija Sajic
David P J Hunt
Woojin Lee
D Alastair S Compston
Judith V Schweimer
Norman A Gregson
Siddharthan Chandran
Kenneth J Smith
author_facet Marija Sajic
David P J Hunt
Woojin Lee
D Alastair S Compston
Judith V Schweimer
Norman A Gregson
Siddharthan Chandran
Kenneth J Smith
author_sort Marija Sajic
collection DOAJ
description Mesenchymal stem cells have been demonstrated to ameliorate experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, prompting clinical trials in multiple sclerosis which are currently ongoing. An important question is whether this therapeutic effect generalises to other autoimmune neurological diseases. We performed two trials of efficacy of MSCs in experimental autoimmune neuritis (EAN) in Lewis (LEW/Han (M)Hsd) rats, a model of human autoimmune inflammatory neuropathies. No differences between the groups were found in clinical, histological or electrophysiological outcome measures. This was despite the ability of mesenchymal stem cells to inhibit proliferation of CD4+ T-cells in vitro. Therefore the efficacy of MSCs observed in autoimmune CNS demyelination models do not necessarily generalise to the treatment of other forms of neurological autoimmunity.
format Article
id doaj-art-ab0991546ffb4c6387d371d835fbb39e
institution DOAJ
issn 1932-6203
language English
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-ab0991546ffb4c6387d371d835fbb39e2025-08-20T03:09:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0172e3070810.1371/journal.pone.0030708Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.Marija SajicDavid P J HuntWoojin LeeD Alastair S CompstonJudith V SchweimerNorman A GregsonSiddharthan ChandranKenneth J SmithMesenchymal stem cells have been demonstrated to ameliorate experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, prompting clinical trials in multiple sclerosis which are currently ongoing. An important question is whether this therapeutic effect generalises to other autoimmune neurological diseases. We performed two trials of efficacy of MSCs in experimental autoimmune neuritis (EAN) in Lewis (LEW/Han (M)Hsd) rats, a model of human autoimmune inflammatory neuropathies. No differences between the groups were found in clinical, histological or electrophysiological outcome measures. This was despite the ability of mesenchymal stem cells to inhibit proliferation of CD4+ T-cells in vitro. Therefore the efficacy of MSCs observed in autoimmune CNS demyelination models do not necessarily generalise to the treatment of other forms of neurological autoimmunity.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0030708&type=printable
spellingShingle Marija Sajic
David P J Hunt
Woojin Lee
D Alastair S Compston
Judith V Schweimer
Norman A Gregson
Siddharthan Chandran
Kenneth J Smith
Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.
PLoS ONE
title Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.
title_full Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.
title_fullStr Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.
title_full_unstemmed Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.
title_short Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.
title_sort mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of t cell proliferation
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0030708&type=printable
work_keys_str_mv AT marijasajic mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation
AT davidpjhunt mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation
AT woojinlee mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation
AT dalastairscompston mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation
AT judithvschweimer mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation
AT normanagregson mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation
AT siddharthanchandran mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation
AT kennethjsmith mesenchymalstemcellslackefficacyinthetreatmentofexperimentalautoimmuneneuritisdespiteinvitroinhibitionoftcellproliferation